2-Amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8H)-one

Catalog No. :
ACEJWG381
CAS No. :
934493-76-2
Molecular Formula :
C13H14N6O
Molecular Weight :
270.30

IUPAC Name:2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8H)-one

2-Amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg99%$54.00Login to see priceInquiryInquiry
25mg99%$91.00Login to see priceInquiryInquiry
50mg99%$144.00Login to see priceInquiryInquiry
100mg99%$235.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8H)-one
IUPAC Name2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8H)-one
Molecular FormulaC13H14N6O
Molecular Weight270.30
SMILESCCN1C2=NC(N)=NC(C)=C2C=C(C3=NNC=C3)C1=O
InChI KeyRGHYDLZMTYDBDT-UHFFFAOYSA-N
SynonymSB16573 | EN300-343327 | DB12400 | Voxtalisib (USAN/INN) | SCHEMBL189573 | CVL1685GPH | SAR 245409 | Voxtalisib [USAN:INN] | D11727 | EX-A4140 | voxtalisib | 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7-one | DTXSID701025755 | SCHE
CAS No.934493-76-2
PubChem CID16123056

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACEJWG381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEJWG381 route product structure diagram
    ACEJWG381934493-76-2
Inquiry

2. ACEJWG381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEJWG381 route product structure diagram
    ACEJWG381934493-76-2
Inquiry

Comments (0)